• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌放疗患者口腔黏膜炎的轨迹及其影响因素

The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and its Influencing Factors.

作者信息

Liu Meizi, An Ran, Wu Zitong, Dai Leping, Zeng Qiaomiao, Chen Wenfeng

机构信息

Teaching and Research Section of Clinical Nursing, Xiangya Hospital Central South University, Changsha, Hunan, China.

Xiang Ya Nursing School, Central South University, Changsha, Hunan, China.

出版信息

Ear Nose Throat J. 2025 May;104(5):NP257-NP269. doi: 10.1177/01455613241228211. Epub 2024 Feb 9.

DOI:10.1177/01455613241228211
PMID:38334289
Abstract

BACKGROUND

Oral mucositis (OM) is a common and severe side effect of radiotherapy in head and neck cancer (HNC). The study aimed to investigate the longitudinal changes in OM and its influencing factors in patients with HNC during radiotherapy.

METHODS

This was a retrospective longitudinal observational study. From July 2022 to March 2023, patients with HNC undergoing radiation therapy were enrolled. OM, oral hygiene, oral infections, oral pain, feeding route, and laboratory indicators were measured at 7 times. The influencing factors of OM were analyzed using generalized estimation equations (GEEs).

RESULTS

A total of 160 patients were included in this study. The prevalence of severe OM at T0, T1, T2, T3, T4, T5, and T6 was 0, 0, 2.5%, 9.4%, 26.9%, 24.4%, and 26.9%, respectively. The prevalence of grade 1-2 OM at T0, T1, T2, T3, T4, T5, and T6 was 0, 16.3%, 53.1%, 65.1%, 61.9%, 70.7%, and 71.3%, respectively. Duration of diagnosis, clinical stage, N stage, M stage, surgery, diabetes, radiotherapy dose, oral hygiene, oral infection, oral pain, feeding route, and lymphocyte impacted OM significantly in the GEEs multivariate model.

CONCLUSIONS

OM occurs in almost all patients with HNC who undergo radiotherapy. Changes in the severity of OM are a dynamic process, with the severity increasing with the cumulative radiotherapy dose. Specialist oral evaluation and oral care are needed to alleviate the severity of OM in HNC patients.

摘要

背景

口腔黏膜炎(OM)是头颈部癌(HNC)放疗常见且严重的副作用。本研究旨在调查HNC患者放疗期间OM的纵向变化及其影响因素。

方法

这是一项回顾性纵向观察研究。纳入2022年7月至2023年3月接受放射治疗的HNC患者。在7个时间点测量OM、口腔卫生、口腔感染、口腔疼痛、进食途径和实验室指标。使用广义估计方程(GEEs)分析OM的影响因素。

结果

本研究共纳入160例患者。T0、T1、T2、T3、T4、T5和T6时重度OM的发生率分别为0、0、2.5%、9.4%、26.9%、24.4%和26.9%。T0、T1、T2、T3、T4、T5和T6时1-2级OM的发生率分别为0、16.3%、53.1%、65.1%、61.9%、70.7%和71.3%。在GEEs多变量模型中,诊断持续时间、临床分期、N分期、M分期、手术、糖尿病、放疗剂量、口腔卫生、口腔感染、口腔疼痛、进食途径和淋巴细胞对OM有显著影响。

结论

几乎所有接受放疗的HNC患者都会发生OM。OM严重程度的变化是一个动态过程,其严重程度随放疗累积剂量增加而增加。需要专业的口腔评估和口腔护理来减轻HNC患者OM的严重程度。

相似文献

1
The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and its Influencing Factors.头颈部癌放疗患者口腔黏膜炎的轨迹及其影响因素
Ear Nose Throat J. 2025 May;104(5):NP257-NP269. doi: 10.1177/01455613241228211. Epub 2024 Feb 9.
2
The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.放疗中累积辐射剂量与头颈部癌症重度口腔黏膜炎发生率的关系。
Cancer Rep (Hoboken). 2021 Apr;4(2):e1317. doi: 10.1002/cnr2.1317. Epub 2020 Dec 9.
3
Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.头颈部癌症调强放疗患者唾液蛋白与口腔黏膜炎相关性的分析:一项纵向研究。
BMC Oral Health. 2024 May 29;24(1):630. doi: 10.1186/s12903-024-04400-9.
4
Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.光生物调节对接受放疗的头颈癌患者口腔黏膜炎严重程度及分子变化的影响:一项成本效益随机临床试验的研究方案
Trials. 2019 Feb 1;20(1):97. doi: 10.1186/s13063-019-3196-8.
5
Status of hydration assessed by bioelectrical impedance analysis: a valuable predictive factor for radiation-induced oral mucositis in head and neck cancer patients.生物电阻抗分析评估的水合状态:头颈部癌症患者放射性口腔黏膜炎的有价值预测因子。
Clin Transl Oncol. 2019 May;21(5):615-620. doi: 10.1007/s12094-018-1963-8. Epub 2018 Oct 16.
6
[Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].[S-1同步放化疗后头颈部癌患者发生重度口腔黏膜炎的危险因素分析]
Yakugaku Zasshi. 2017;137(2):221-225. doi: 10.1248/yakushi.16-00077.
7
The prevalence of oral mucositis after radiotherapy in patients with Head and Neck Cancer and its associated factors: a meta-analysis.头颈部癌患者放疗后口腔黏膜炎的患病率及其相关因素:一项荟萃分析。
Clin Transl Oncol. 2025 Apr;27(4):1767-1778. doi: 10.1007/s12094-024-03706-y. Epub 2024 Sep 14.
8
Changes and predictors of radiation-induced oral mucositis in patients with oral cavity cancer during active treatment.口腔癌患者在积极治疗期间放射性口腔黏膜炎的变化及预测因素。
Eur J Oncol Nurs. 2015 Jun;19(3):214-9. doi: 10.1016/j.ejon.2014.12.001. Epub 2015 Jan 10.
9
Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients.TNFRSF1A基因启动子区域多态性(-610T>G)作为头颈部肿瘤患者放疗诱发口腔黏膜炎的新型预测因子
Pathol Oncol Res. 2018 Jan;24(1):135-143. doi: 10.1007/s12253-017-0227-1. Epub 2017 Apr 11.
10
Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.对头颈部癌放疗期间口腔黏膜炎及其对生活质量和患者报告结局的前瞻性评估。
Med Oncol. 2017 May;34(5):81. doi: 10.1007/s12032-017-0950-1. Epub 2017 Apr 6.

引用本文的文献

1
Advancing oral cancer care: nanomaterial-driven diagnostic and therapeutic innovations.推进口腔癌护理:纳米材料驱动的诊断与治疗创新
Cell Biol Toxicol. 2025 May 23;41(1):90. doi: 10.1007/s10565-025-10027-5.
2
Designing novel cabozantinib analogues as p-glycoprotein inhibitors to target cancer cell resistance using molecular docking study, ADMET screening, bioisosteric approach, and molecular dynamics simulations.利用分子对接研究、ADMET筛选、生物电子等排方法和分子动力学模拟设计新型卡博替尼类似物作为P-糖蛋白抑制剂,以靶向癌细胞耐药性。
Front Chem. 2025 Feb 27;13:1543075. doi: 10.3389/fchem.2025.1543075. eCollection 2025.
3
Bacteria-tumor symbiosis destructible novel nanocatalysis drug delivery systems for effective tumor therapy.
用于有效肿瘤治疗的可破坏细菌-肿瘤共生关系的新型纳米催化药物递送系统。
Nanomedicine (Lond). 2025 Feb;20(3):305-318. doi: 10.1080/17435889.2024.2443388. Epub 2024 Dec 30.
4
Evaluating Cetuximab Regimens in Head and Neck Cancer: Insights from a Retrospective Cohort Study.评估西妥昔单抗方案治疗头颈癌:一项回顾性队列研究的见解
Cancers (Basel). 2025 Jan 10;17(2):210. doi: 10.3390/cancers17020210.
5
Detection of genomic variants in BRCA1 and BRCA2 across gastric cancer patients using next generation sequencing.使用下一代测序技术检测胃癌患者BRCA1和BRCA2基因中的基因组变异。
Am J Transl Res. 2024 Dec 15;16(12):7898-7910. doi: 10.62347/MRIE2131. eCollection 2024.
6
Comprehensive investigation of matrix metalloproteinases in skin cutaneous melanoma: diagnostic, prognostic, and therapeutic insights.皮肤黑色素瘤中基质金属蛋白酶的综合研究:诊断、预后及治疗见解
Sci Rep. 2025 Jan 16;15(1):2152. doi: 10.1038/s41598-025-85887-2.
7
Evaluation of efficacy of GCSF in reducing neutropenia among carcinoma patients undergoing anti-cancer chemotherapy. A prospective cohort study.评估粒细胞集落刺激因子(GCSF)在降低接受抗癌化疗的癌症患者中性粒细胞减少症方面的疗效。一项前瞻性队列研究。
PLoS One. 2025 Jan 2;20(1):e0315435. doi: 10.1371/journal.pone.0315435. eCollection 2025.
8
Correlation Analysis Between Prognostic Nutritional Index Trajectory Categories and Radiotherapy-induced Severe Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy.接受放疗的头颈癌患者预后营养指数轨迹类别与放疗引起的严重口腔黏膜炎之间的相关性分析
Oral Health Prev Dent. 2024 Dec 12;22:671-680. doi: 10.3290/j.ohpd.b5877400.
9
Enhancing Predictive Accuracy for Recurrence-Free Survival in Head and Neck Tumor: A Comparative Study of Weighted Fusion Radiomic Analysis.提高头颈部肿瘤无复发生存的预测准确性:加权融合放射组学分析的比较研究
Diagnostics (Basel). 2024 Sep 14;14(18):2038. doi: 10.3390/diagnostics14182038.
10
Comment on: Does the Planning Target Volume Correlate with Toxicity for Head and Neck Cancer Patients Undergoing Radiation? A Prospective Observational Study.评论:接受放疗的头颈癌患者的计划靶体积与毒性是否相关?一项前瞻性观察性研究。
Indian J Surg Oncol. 2024 Sep;15(Suppl 3):481-482. doi: 10.1007/s13193-024-02045-2. Epub 2024 Jul 28.